Breakthrough Targeted Therapy Shows Promise for KRAS-Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role
FOR IMMEDIATE RELEASE Breakthrough Targeted Therapy Shows Promise for KRAS-Mutated Pancreatic Cancer, with Virginia Cancer Specialists and NEXT Oncology Playing Key Role Fairfax, VA — May 12, 2026 — Virginia Cancer Specialists announced today its participation as a leading clinical trial site in a landmark study evaluating daraxonrasib, a first-in-class targeted oral therapy for patients […]
Virginia Cancer Specialists Earns Re-Certification from QOPI® for Excellence in Oncology Care
Virginia Cancer Specialists has received re-certification by the QOPI® Certification Program, LLC, a wholly owned subsidiary of the Association for Clinical Oncology (the Association) and an affiliate of the American Society of Clinical Oncology (the Society). The QOPI® Certification Program builds on the Society’s Quality Oncology Practice Initiative (QOPI®), providing a three-year certification for outpatient […]
Improved Survival with a Chemotherapy Free Option for EGFR Mutated Lung Cancer
Living with advanced non–small cell lung cancer (NSCLC) driven by mutations in the EGFR gene can feel overwhelming. For many patients, treatment has meant targeted therapy with the gold standard osimertinib, an oral targeted therapy directed toward the EGFR mutated tumor cells. Data from the large MARIPOSA trial published in September 2025 in The New […]
New Treatment Breakthrough: Amivantamab Plus Lazertinib for Advanced Lung Cancer – Timothy A. McCarthy, MD
A groundbreaking study published in June 2024 in The New England Journal of Medicine has introduced a promising new treatment for a specific type of advanced lung cancer. The research, co-authored by Alex Spira, MD, PhD, FACP, FACSO, Medical Oncologist and Co-Director of The Virginia Cancer Specialists Research Institute, highlights the combination of two drugs, […]
Lymphedema Awareness Month -Shedding Light on Breast Cancer-Related Arm Lymphedema: A Call for Awareness and Action
Lymphedema Awareness Month – Part 1 March is a time dedicated to raising awareness about lymphedema, a condition that affects millions worldwide. Among the various forms of lymphedema, breast cancer-related arm lymphedema (BCRAL) stands out as a significant concern, impacting up to 20% of breast cancer survivors. As we mark Lymphedema Awareness Month, it’s crucial […]
Revolutionizing Breast Cancer Care: Insights and Recommendations from a Pivotal Germline Mutation Testing Study
Dr. Patricia Rodriguez of Virginia Cancer Specialists, is a co-author of the joint guideline paper issued by the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) that aims to provide evidence-based recommendations for healthcare professionals dealing with precision care for breast cancer patients. The main goal of this paper was […]
Enhancing Lung Cancer Treatment: The Promise of Perioperative Immunotherapy – Samantha DiBenedetto, MD
Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of Dr. Alex Spira, the AEGEAN trial, was published in the New England Journal of Medicine (NEJM) earlier this month and has shed light […]